Workflow
Longevity Insurance
icon
Search documents
RGA Stock Trading at Discount to Industry at 1X: Time to Hold?
ZACKS· 2026-01-14 16:05
Key Takeaways New business, stable in-force earnings and favorable longevity trends support RGA's outlook. RGA sees growth from global protection demand and rising retirement and savings needs. Strong cash flow, tech adoption and active capital deployment bolster RGA's long-term path. Reinsurance Group of America (RGA) shares are trading at a discount to the Zacks Life Insurance industry. Its forward price-to-book value of 1X is lower than the industry average of 2X, the Finance sector’s 4.36X and the Zacks ...
RGA Stock Trades Above 50-Day SMA: What Should Investors Do?
ZACKS· 2025-12-05 15:06
Core Insights - Reinsurance Group of America (RGA) is currently trading above its 50-day simple moving average, indicating a short-term bullish trend, with a share price of $192.61, down 17.3% from its 52-week high of $232.97 [1] - RGA has a market capitalization of $12.73 billion, with an average trading volume of 0.4 million shares over the last three months [2] Valuation Metrics - RGA shares are trading at a price-to-book value of 0.97X, which is lower than the industry average of 1.86X, the Finance sector's 4.23X, and the Zacks S&P 500 Composite's 8.53X, indicating a better entry point for investors [3] - The average target price for RGA, based on estimates from 10 analysts, is $239.10 per share, suggesting a potential upside of 26.29% from the last closing price [11] Financial Performance - RGA's revenue for 2025 is estimated at $23.55 billion, reflecting a year-over-year improvement of 3%, with projected increases of 18.1% in earnings per share and 11% in revenues for 2026 [10] - The return on invested capital (ROIC) for RGA has increased annually, reaching 5.52% in the trailing 12 months, significantly higher than the industry average of 0.6% [13] Market Position and Growth Drivers - RGA is a leader in the U.S. and Latin American markets, with a strong product line and capabilities that support stable earnings and capital generation [14] - The company anticipates growth driven by global protection demand and rising retirement and savings needs, particularly in the Canadian market where longevity insurance is expected to see steady demand [18][19] Operational Efficiency - RGA has maintained a free cash flow conversion rate of over 85% in recent quarters, indicating solid earnings and effective capital management [20] - The company is actively managing capital through share buybacks, dividend payments, and prudent investments, while also seeking attractive growth opportunities [21] Long-term Outlook - RGA's new business volumes, favorable longevity experience, diversified business model, and effective capital deployment are expected to favor the company in the long term [22]
Reinsurance Group Stock Plunges 11.1% YTD: How Should You Play?
ZACKS· 2025-08-14 17:36
Core Insights - Reinsurance Group of America (RGA) shares have declined by 11.1% year-to-date, contrasting with a 2.5% decline in the industry, while the Finance sector and the S&P 500 have gained 10.6% and 9.5%, respectively [1][7] - RGA has a market capitalization of $12.6 billion, with an average trading volume of 0.4 million shares over the last three months [1] Valuation and Market Position - RGA shares are trading at a price-to-book value of 1.03X, which is lower than the industry average of 1.66X, indicating that RGA shares are relatively affordable [4] - The average target price for RGA, based on estimates from 11 analysts, is $239 per share, suggesting a potential upside of 28.3% from the last closing price [5] Financial Performance - In Q2, RGA's net investment income surged by 30.1% to $1.4 billion, with yields increasing by 66 basis points to 5.3% [7][14] - The Zacks Consensus Estimate for RGA's 2025 revenues is $23.4 billion, reflecting a year-over-year improvement of 2.5% [9] - Current-year earnings are estimated at $22.73 per share, up 0.7% from the previous year, while 2026 earnings per share and revenues are projected to increase by 9.8% and 12.5%, respectively, from 2025 estimates [9] Analyst Sentiment and Estimates - Analysts have recently lowered their earnings estimates for RGA for 2025 and 2026 by 1.5% and 0.5%, respectively, over the past 30 days [10] - The adjusted operating return on equity (ROE) for Q2 2025 has decreased by 100 basis points to 14.3%, with trailing 12-month ROE falling by 320 basis points year-over-year to 12.6% [16] Market Leadership and Growth Potential - RGA leads the reinsurance markets in the U.S., Latin America, and Canada, with a strong focus on individual mortality segments that provide stable earnings and capital generation [11][12] - The company benefits from a sizable in-force business that supports steady earnings and has seen long-term growth in net investment income, with a 17.2% compound annual growth rate (CAGR) from 2016 to 2024 [14] Challenges and Financial Health - Rising expenses from higher claims, interest credited, operating costs, and interest expenses could pressure margins [15] - Long-term debt has increased by 13.7% since the end of 2024, reaching $5.73 billion, which has pushed the total debt-to-capital ratio up by 50 basis points to 32.1 [16]
RGA Stock Trading at Discount to Industry at 1.14X: Time to Hold?
ZACKS· 2025-06-27 15:00
Core Insights - Reinsurance Group of America (RGA) shares are trading at a discount compared to the Zacks Life Insurance industry, with a forward price-to-book value of 1.14X, lower than the industry average of 1.97X, the Finance sector's 4.18X, and the S&P 500 Composite's 8.18X [2] - RGA has a market capitalization of $13.13 billion and an average trading volume of 0.4 million shares over the last three months [2] - The company has a Value Score of A, indicating strong valuation metrics [2] Price Performance - RGA shares have lost 3.2% over the past year, while the industry has grown by 14.8%, the Finance sector by 19.7%, and the S&P 500 composite by 11.3% [5] - RGA shares are currently trading above the 50-day simple moving average of $197.98, indicating solid upward momentum [4] Earnings and Growth - RGA has a decent earnings surprise history, beating estimates in three of the last four quarters with an average surprise of 7.85% [6] - Earnings have grown by 15.3% over the past five years, outperforming the industry average of 7.8%, and the company has a Growth Score of B [11] - The Zacks Consensus Estimate for RGA's 2025 earnings per share indicates a year-over-year increase of 2.2%, with revenues projected at $23.45 billion, reflecting a 2.6% improvement [10] Analyst Sentiment and Target Price - The average target price for RGA, based on short-term price targets from 11 analysts, is $244.64 per share, suggesting a potential upside of 25.1% from the last closing price [12] Return on Invested Capital - RGA's return on invested capital (ROIC) has increased annually, with a trailing 12-month ROIC of 6%, significantly higher than the industry average of 0.6% [15] Market Position and Strategy - RGA is a leader in the traditional U.S. and Latin American markets, with a strong product line and significant value embedded in its in-force business, which is expected to generate predictable long-term earnings [17] - The company is well-capitalized and actively seeks growth opportunities while balancing capital returns to shareholders [19] - RGA is ramping up technological inclusion in its products and has maintained a free cash flow conversion rate above 85% in recent quarters [20] Final Assessment - RGA's new business volumes, favorable longevity experience, diversified business model, and effective capital deployment position it well for long-term growth [22] - The stock has a VGM Score of A, indicating attractive value, growth, and momentum [22] - Given the solid growth projections and attractive valuations, RGA is considered a stock to hold [23]
Reinsurance Group Trades at a Discount: How to Play the Stock
ZACKS· 2025-04-02 13:55
Core Viewpoint - Reinsurance Group of America (RGA) shares are trading at a discount compared to the industry average, indicating potential investment opportunities due to its strong fundamentals and growth prospects [1][2]. Financial Metrics - RGA has a market capitalization of $13.09 billion and a forward price-to-book value of 1.2X, lower than the industry average of 1.83X, the Finance sector's 4.05X, and the S&P 500 Composite's 7.89X [1][2]. - The average trading volume over the last three months was 0.5 million shares [2]. Price Performance - RGA's shares have gained 2.4% over the past year, underperforming the industry growth of 13.8%, the Finance sector's return of 15.4%, and the S&P 500 composite's appreciation of 8.1% [3]. Earnings Surprise History - RGA has a solid earnings surprise history, beating estimates in three of the last four quarters with an average surprise of 14.67% [4]. Growth Projections - The Zacks Consensus Estimate for RGA's 2025 earnings per share indicates a year-over-year increase of 1.8%, with revenues projected at $24.22 billion, reflecting a 7.3% improvement [5]. - For 2026, earnings per share and revenues are expected to increase by 8.6% and 8.7%, respectively, from the 2024 estimates [5]. Historical Earnings Growth - RGA's earnings have grown by 15.3% over the past five years, outperforming the industry average of 7.8% [6]. Return on Invested Capital - RGA's return on invested capital (ROIC) has consistently increased, reaching 6.3% in the trailing 12 months, significantly higher than the industry average of 0.6% [7]. Market Position and Strategy - RGA is a leader in the U.S. and Latin American markets, with a strong product line and capabilities that contribute to stable earnings and capital generation [10]. - In Canada, RGA holds a significant block of in-force business, which is expected to drive future earnings, particularly in longevity insurance [11]. - The company is well-capitalized and plans to deploy capital in attractive growth opportunities while returning excess capital to shareholders [12][14]. Technological Integration - RGA is enhancing its product offerings through technological advancements and is recognized as a global leader in biometric liability reinsurance [13]. Capital Management - The company effectively manages capital through share buybacks, dividends, and prudent investments, aiming to balance growth opportunities with shareholder returns [14]. Long-term Outlook - RGA's diversified business model, favorable longevity experience, and effective capital deployment strategies position it well for long-term growth [15].